Plain-English translation of NCT07550777 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand whether bevacizumab, a medication injected into the eye to treat diabetic vision loss, retinal vein blockage, and age-related macular degeneration, might affect your heart and blood vessel health over time. The study will measure specific enzymes and blood fats in people who have received multiple eye injections and compare them to healthy people who haven't had this treatment. This will help doctors understand whether the medication is safe for your cardiovascular system when used repeatedly.
When this medication is used systemically (throughout the whole body) for cancer treatment, it can raise the risk of blood clots and bleeding. Although the eye injections deliver much smaller doses, patients receive them repeatedly over months or years. Doctors need to know whether these repeated injections might slowly affect heart health and blood vessel function, so they can make the safest treatment decisions.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will have a single visit where researchers will take a blood sample and ask about your medical history. The blood will be analyzed to measure specific enzymes and fats that reflect heart health and inflammation. The study compares results between people who have received the eye injections and healthy volunteers, so the main activity is providing one blood sample.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Turkey (Türkiye)